(25 days)
Not Found
No
The description focuses on automation of standard laboratory processes and an operating system upgrade, with no mention of AI or ML technologies.
No
The device is an automated clinical instrument used for performing tests on human plasmas to aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy. It analyzes samples and reports results, which are diagnostic in nature, not therapeutic.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device "aid[s] in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy."
No
The device description clearly states it is a "fully automatic clinical instrument" that performs physical actions like sample handling, reagent delivery, and analysis, indicating it includes hardware components beyond just software. The software is described as controlling these hardware functions.
Yes, based on the provided information, the STA-R® Evolution (or STA-R®) Automated Multi-Parametric Analyzer is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the device is "indicated and intended for the performance of tests on human plasmas, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy." This clearly describes a diagnostic purpose performed on biological samples in vitro (outside the body).
- Device Description: The description details a system that handles samples and reagents, performs analysis, and reports results. This aligns with the typical function of an IVD instrument used in a clinical laboratory setting.
- Use of Reagents: The mention of using "Diagnostica Stago reagents in addition to open adaptation of other currently available reagents" further supports its role in performing diagnostic tests using chemical or biological reagents.
- Performance of Tests: The device performs "clotting time or clot-based tests (i.e. chronometric) measurements and photometric assays (at specific wave lengths) on plasma samples," which are common types of in vitro diagnostic tests.
The fact that it's an automated analyzer designed for clinical use and performs tests on human plasma to aid in diagnosis and monitoring therapy are all key indicators of an IVD.
N/A
Intended Use / Indications for Use
The STA-R® Evolution (or STA-R®) Automated Multi-Parametric Analyzer is a fully automatic clinical instrument indicated and intended for the performance of tests on human plasmas, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.
Product codes
JPA
Device Description
The STA-R® Automated Multi-Parametric Analyzer is designed as a fully automatic system. Samples and test reagents are loaded into the instrument where sample handling, reagent delivery, analysis, and reporting of results are performed automatically. A central processing unit controls instrument functions such as, management of patient results, quality control, system supervision, support for instrument maintenance, and work load optimization. The STA-R® Evolution is the modified or updated version of the company's STA-R®, legally marketed predicate device. The modification of the device involves the upgrade of the instrument's operating system from Windows NT to the Windows XP platform. Slight modifications to the application software were made to accommodate the new operating system along with operator/user enhancements but without logic configuration changes.
The instrument utilizes Diagnostica Stago reagents in addition to open adaptation of other currently available reagents. Barcoding of test reagents, calibrators, and controls facilitate their use on the system and permits reagent management simple. Manual entry of reagent information enables the use of non-barcoded reagents.
The instrument performs multiple test methodologies in random access as selected by the user. These include clotting time or clot-based tests (i.e. chronometric) measurements and photometric assays (at specific wave lengths) on plasma samples.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Risk Assessment and validation study demonstrate that the STA-R® Evolution is as safe and effective as the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 864.5425 Multipurpose system for in vitro coagulation studies.
(a)
Identification. A multipurpose system for in vitro coagulation studies is a device consisting of one automated or semiautomated instrument and its associated reagents and controls. The system is used to perform a series of coagulation studies and coagulation factor assays.(b)
Classification. Class II (special controls). A control intended for use with a multipurpose system for in vitro coagulation studies is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
0
Image /page/0/Picture/0 description: The image contains a sequence of alphanumeric characters. The characters appear to be handwritten and include the letter 'K' followed by the numbers '082675'. The characters are all connected and written in black ink. The image is a close-up of the characters.
Image /page/0/Picture/1 description: The image shows the logo for Stago. The logo consists of the word "Stago" in a serif font, with a stylized graphic above it. The graphic appears to be three curved shapes arranged in a circular or triangular pattern, creating a sense of movement or rotation. The logo is simple and modern, with a focus on typography and abstract design.
CONFIDENTIAL
Attachment - 6
510(k) SUMMARY
OCT 1 0 2008
Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared:
Umberto V. Parrotta Diagnostica Stago, Inc. Five Century Drive Parsippany, New Jersey 07054
Phone: (973) 631-1200, x-2044 Facsimile: (973) 695-0095
Contact Person: Umberto V. Parrotta
Date Prepared: September 11, 2008
Name of Modified Device and Name/Address of Sponsor:
STA-R® Evolution/Expert Series or STA-R®
Diagnostica Stago, Inc. Five Century Drive Parsippany, New Jersey 07054
Common or Usual Name:
- . IVD Coagulation Device/Instrument.
- Automated and Semi-Automated Hematology Device. �
- Multi-Parametric Analyzer
Classification Name:
System, Multipurpose for In Vitro Coagulation Studies
Predicate Devices:
- . Diagnostica Stago's STA-R® Automated Multi-Parametric Analyzer (K983460).
Purpose of the Special 510(k) Notice:
- . The STA-R® Evolution is a modification to the company's own legally marketed device, STA-R®.
File: DSI-STAR-EvolutionXPOS-Attachment-06-510(k)Summary.doc
1
Image /page/1/Picture/1 description: The image shows the logo for Stago. The logo consists of the word "Stago" in a simple, sans-serif font, with the letters evenly spaced. Above the word "Stago" is an abstract graphic element. The graphic element is composed of two curved shapes, one larger and one smaller, arranged to suggest a stylized, incomplete circle or a crescent moon shape.
Attachment - 6
510(k) SUMMARY
- . The modification of the device involves the upgrade of the instrument's operating system from Windows NT to the Windows XP platform. Slight modifications to the application software were made to accommodate the new operating system along with operator/user enhancements but without logic configuration changes.
Indication/Intended Use:
The STA-R® Evolution (or STA-R®) Automated Multi-Parametric Analyzer is a fully automatic clinical instrument indicated and intended for the performance of tests on human plasmas, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.
Technological Characteristics:
The STA-R® Automated Multi-Parametric Analyzer is designed as a fully automatic system. Samples and test reagents are loaded into the instrument where sample handling, reagent delivery, analysis, and reporting of results are performed automatically. A central processing unit controls instrument functions such as, management of patient results, quality control, system supervision, support for instrument maintenance, and work load optimization. The STA-R® Evolution is the modified or updated version of the company's STA-R®, legally marketed predicate device. The modification of the device involves the upgrade of the instrument's operating system from Windows NT to the Windows XP platform. Slight modifications to the application software were made to accommodate the new operating system along with operator/user enhancements but without logic configuration changes.
The instrument utilizes Diagnostica Stago reagents in addition to open adaptation of other currently available reagents. Barcoding of test reagents, calibrators, and controls facilitate their use on the system and permits reagent management simple. Manual entry of reagent information enables the use of non-barcoded reagents.
The instrument performs multiple test methodologies in random access as selected by the user. These include clotting time or clot-based tests (i.e. chronometric) measurements and photometric assays (at specific wave lengths) on plasma samples. The Technological Characteristics and Principles of Operation for the aforementioned analyses are the same between the subject submission device and the predicate device.
2
Image /page/2/Picture/0 description: The image shows the logo for Stago. The logo consists of the word "Stago" in a sans-serif font, with a stylized graphic above it. The graphic is composed of three curved shapes arranged in a circular pattern, resembling a stylized flower or abstract design. The logo is simple and modern in appearance.
Attachment - 6
510(k) SUMMARY
Substantial Equivalence:
The STA-R® Evolution has the same intended use and indications, principles of operation, and technological characteristics as the STA-R® (K983460) predicate device. The differences in the operating system software and slight operator/user enhancements to the instrument's application software do not raise any new questions of safety or effectiveness. The Risk Assessment and validation study demonstrate that the STA-R® Evolution is as safe and effective as the predicate device. Thus, the STA-R® Evolution is substantially equivalent to its predicate devices.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus.
Public Health Service
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
OCT 1 0 2008
Diagnostica Stago, Inc. c/o Mr. Umberto Parrotta Director of Regulatory Affairs & Quality Assurance 5 Century Drive Parsippany, NJ 07054
Re: K082675
Trade/Device Name: STA-R® Evolution /Expert Series Automated Multi-Parametric Analyzer Regulation Number: 21 CFR 864.5425 Regulation Name: Multipurpose system for in vitro coagulation studies Regulatory Class: Class II Product Code: JPA Dated: September 12, 2008 Received: September 15, 2008
Dear Mr. Parrotta:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
4
Page 2
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Maria Mchen
Maria M. Chan, Ph.D. Acting Division Director Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
5
Image /page/5/Picture/0 description: The image shows the logo for "Stago". The logo consists of the word "Stago" in a serif font, with a stylized graphic above it. The graphic appears to be an abstract shape, possibly representing a stylized "S" or a geometric design. The logo is simple and clean, with a focus on the company name and a distinctive visual element.
Attachment - 2A
Indications for Use Form
510(k) Number (if known):
Device Name:
STA-R® Evolution/Expert Series Automated Multi-Parametric Analyzer
Indications for Use:
The STA-R® Evolution/Expert Series is a fully automatic clinical instrument designed for the performance of tests on human plasmas, the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy.
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use X
(Per 21 C.F.R. 801.109)
OR
Over-The-Counter Use
Mana m. Chan (Optional Format 1-2-96)
Division Sign-Off
Office of In Vitro Diagnostic e Evaluation and
510(k) K082675
File: DSI-STAR-EvolutionXPOS-Attachment-02A-IndicationsForUseStatementForm.doc Page 1 of 1